Neoadjuvant niraparib in men with DNA repair gene deficient clinically localized prostate cancer: Clinical and molecular results from a phase 2 investigator-initiated trial.Marc Dall’Era, Primo N. Lara, Mamta Parikh et al.|Journal of Clinical Oncology|2025Cited by 1